132 related articles for article (PubMed ID: 24875648)
1. Use of herbal medicines and natural products: an alternative approach to overcoming the apoptotic resistance of pancreatic cancer.
Li L; Leung PS
Int J Biochem Cell Biol; 2014 Aug; 53():224-36. PubMed ID: 24875648
[TBL] [Abstract][Full Text] [Related]
2. Lupeol, a fruit and vegetable based triterpene, induces apoptotic death of human pancreatic adenocarcinoma cells via inhibition of Ras signaling pathway.
Saleem M; Kaur S; Kweon MH; Adhami VM; Afaq F; Mukhtar H
Carcinogenesis; 2005 Nov; 26(11):1956-64. PubMed ID: 15958516
[TBL] [Abstract][Full Text] [Related]
3. Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro.
Bai J; Sui J; Demirjian A; Vollmer CM; Marasco W; Callery MP
Cancer Res; 2005 Mar; 65(6):2344-52. PubMed ID: 15781649
[TBL] [Abstract][Full Text] [Related]
4. Par-4 downregulation confers cisplatin resistance in pancreatic cancer cells via PI3K/Akt pathway-dependent EMT.
Tan J; You Y; Xu T; Yu P; Wu D; Deng H; Zhang Y; Bie P
Toxicol Lett; 2014 Jan; 224(1):7-15. PubMed ID: 24144893
[TBL] [Abstract][Full Text] [Related]
5. Markers involved in resistance to cytotoxics and targeted therapeutics in pancreatic cancer.
El Maalouf G; Le Tourneau C; Batty GN; Faivre S; Raymond E
Cancer Treat Rev; 2009 Apr; 35(2):167-74. PubMed ID: 19027240
[TBL] [Abstract][Full Text] [Related]
6. Bruceine D induces apoptosis in pancreatic adenocarcinoma cell line PANC-1 through the activation of p38-mitogen activated protein kinase.
Lau ST; Lin ZX; Liao Y; Zhao M; Cheng CH; Leung PS
Cancer Lett; 2009 Aug; 281(1):42-52. PubMed ID: 19286308
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis Triggering, an Important Way for Natural Products From Herbal Medicines to Treat Pancreatic Cancers.
Li M; Tang D; Yang T; Qian D; Xu R
Front Pharmacol; 2021; 12():796300. PubMed ID: 35222011
[TBL] [Abstract][Full Text] [Related]
8. Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activation.
Wei WT; Chen H; Ni ZL; Liu HB; Tong HF; Fan L; Liu A; Qiu MX; Liu DL; Guo HC; Wang ZH; Lin SZ
Int J Oncol; 2011 Dec; 39(6):1381-90. PubMed ID: 21805032
[TBL] [Abstract][Full Text] [Related]
9. Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70.
Phillips PA; Dudeja V; McCarroll JA; Borja-Cacho D; Dawra RK; Grizzle WE; Vickers SM; Saluja AK
Cancer Res; 2007 Oct; 67(19):9407-16. PubMed ID: 17909050
[TBL] [Abstract][Full Text] [Related]
10. Induction of reactive oxygen species renders mutant and wild-type K-ras pancreatic carcinoma cells susceptible to Ad.mda-7-induced apoptosis.
Lebedeva IV; Su ZZ; Sarkar D; Gopalkrishnan RV; Waxman S; Yacoub A; Dent P; Fisher PB
Oncogene; 2005 Jan; 24(4):585-96. PubMed ID: 15580305
[TBL] [Abstract][Full Text] [Related]
11. A novel herbal formula induces cell cycle arrest and apoptosis in association with suppressing the PI3K/AKT pathway in human lung cancer A549 cells.
Xiong F; Jiang M; Huang Z; Chen M; Chen K; Zhou J; Yin L; Tang Y; Wang M; Ye L; Zhan Z; Duan J; Fu H; Zhang X
Integr Cancer Ther; 2014 Mar; 13(2):152-60. PubMed ID: 24105357
[TBL] [Abstract][Full Text] [Related]
12. Multiple kinase pathways involved in the different de novo sensitivity of pancreatic cancer cell lines to 17-AAG.
Liu H; Zhang T; Chen R; McConkey DJ; Ward JF; Curley SA
J Surg Res; 2012 Jul; 176(1):147-53. PubMed ID: 22099584
[TBL] [Abstract][Full Text] [Related]
13. HSP70 desensitizes osteosarcoma cells to baicalein and protects cells from undergoing apoptosis.
Ding L; He S; Sun X
Apoptosis; 2014 Aug; 19(8):1269-80. PubMed ID: 24846187
[TBL] [Abstract][Full Text] [Related]
14. Modulation of cell sensitivity to antitumor agents by targeting survival pathways.
Perego P; Cossa G; Zuco V; Zunino F
Biochem Pharmacol; 2010 Nov; 80(10):1459-65. PubMed ID: 20688050
[TBL] [Abstract][Full Text] [Related]
15. BCL-2 functions as an activator of the AKT signaling pathway in pancreatic cancer.
Mortenson MM; Galante JG; Gilad O; Schlieman MG; Virudachalam S; Kung HJ; Bold RJ
J Cell Biochem; 2007 Dec; 102(5):1171-9. PubMed ID: 17960583
[TBL] [Abstract][Full Text] [Related]
16. Targeting XIAP bypasses Bcl-2-mediated resistance to TRAIL and cooperates with TRAIL to suppress pancreatic cancer growth in vitro and in vivo.
Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Gschwend JE; Simmet T; Debatin KM; Fulda S
Cancer Res; 2008 Oct; 68(19):7956-65. PubMed ID: 18829553
[TBL] [Abstract][Full Text] [Related]
17. Regulation of the resistance to TRAIL-induced apoptosis as a new strategy for pancreatic cancer.
Mori T; Doi R; Toyoda E; Koizumi M; Ito D; Kami K; Kida A; Masui T; Kawaguchi Y; Fujimoto K
Surgery; 2005 Jul; 138(1):71-7. PubMed ID: 16003319
[TBL] [Abstract][Full Text] [Related]
18. Terapeutic importance of apoptosis pathways in pancreatic cancer.
Olechowska-Jarząb A; Ptak-Belowska A; Brzozowski T
Folia Med Cracov; 2016; 56(1):61-70. PubMed ID: 27513839
[TBL] [Abstract][Full Text] [Related]
19. Selective induction of apoptosis: promising therapy in pancreatic cancer.
Liu Z; Li D; Zheng X; Wang E; Wang J
Curr Pharm Des; 2013; 19(12):2259-68. PubMed ID: 23082976
[TBL] [Abstract][Full Text] [Related]
20. Molecular signature of pancreatic adenocarcinoma: an insight from genotype to phenotype and challenges for targeted therapy.
Sahin IH; Iacobuzio-Donahue CA; O'Reilly EM
Expert Opin Ther Targets; 2016; 20(3):341-59. PubMed ID: 26439702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]